SKŘIČKOVÁ, Jana, Marcela TOMÍŠKOVÁ, Irena VAŠUTOVÁ, Bohdan KADLEC, Jana KAPLANOVÁ, Lenka BABIČKOVÁ, Pavel TURČÁNI, Tomáš NEBESKÝ, Leoš KŘEN a Lucie BUREŠOVÁ. Analysis of clinical factors in relationship to treatment effects of erlotinib in non small cell lung cancer (NSCLC) patiients. European Respiratory Journal. Berlin: 18 th ERS Annual Congress, 2008, roč. 32, supl 52, s. 1399-1401. ISSN 0904-1850. |
Další formáty:
BibTeX
LaTeX
RIS
@article{784654, author = {Skřičková, Jana and Tomíšková, Marcela and Vašutová, Irena and Kadlec, Bohdan and Kaplanová, Jana and Babičková, Lenka and Turčáni, Pavel and Nebeský, Tomáš and Křen, Leoš and Burešová, Lucie}, article_location = {Berlin}, article_number = {supl 52}, keywords = {non small cell lung cancer; clinical analysis; erlotinib}, language = {eng}, issn = {0904-1850}, journal = {European Respiratory Journal}, title = {Analysis of clinical factors in relationship to treatment effects of erlotinib in non small cell lung cancer (NSCLC) patiients}, volume = {32}, year = {2008} }
TY - JOUR ID - 784654 AU - Skřičková, Jana - Tomíšková, Marcela - Vašutová, Irena - Kadlec, Bohdan - Kaplanová, Jana - Babičková, Lenka - Turčáni, Pavel - Nebeský, Tomáš - Křen, Leoš - Burešová, Lucie PY - 2008 TI - Analysis of clinical factors in relationship to treatment effects of erlotinib in non small cell lung cancer (NSCLC) patiients JF - European Respiratory Journal VL - 32 IS - supl 52 SP - 1399 EP - 1399 PB - 18 th ERS Annual Congress SN - 09041850 KW - non small cell lung cancer KW - clinical analysis KW - erlotinib N2 - Analysis of clinical factors in relationship to treatment effects of erlotinib in non small cell lung cancer (NSCLC) patiients An analysis is presented of clinical factors in relationship to the treatment with erlotinib in non-small cell lung cancer. ER -
SKŘIČKOVÁ, Jana, Marcela TOMÍŠKOVÁ, Irena VAŠUTOVÁ, Bohdan KADLEC, Jana KAPLANOVÁ, Lenka BABIČKOVÁ, Pavel TURČÁNI, Tomáš NEBESKÝ, Leoš KŘEN a Lucie BUREŠOVÁ. Analysis of clinical factors in relationship to treatment effects of erlotinib in non small cell lung cancer (NSCLC) patiients. \textit{European Respiratory Journal}. Berlin: 18 th ERS Annual Congress, 2008, roč.~32, supl 52, s.~1399-1401. ISSN~0904-1850.
|